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SUMMARY 
The quality of clinical research in surgery has long attracted criticism. High quality randomised trials 
have proved difficult to conduct in surgery, and many surgical treatments have therefore been 
adopted without adequate supporting evidence of efficacy and safety.  This evidence deficit can 
adversely affect research funding and re-imbursement decisions, slow adoption of innovations, and 
permit widespread adoption of procedures which offer no benefit or cause harm.  Improvement in 
the quality of surgical evidence would therefore be very valuable. The IDEAL Framework and 
Recommendations specify desirable qualities for surgical studies, and outline an integrated 
evaluation pathway for surgery and similar complex interventions.  We used the IDEAL 
Recommendations to assess methodological progress in surgical research over time, assessed the 
uptake and influence of IDEAL and identified the challenges to further methodological progress . 
Comparing studies from the periods 2000 - 2004 and 2010-2014, we noted apparent improvement in 
the use of standard outcome measures, adoption of CONSORT standards, evaluation of the quality of 
surgery and of learning curves, but no progress in the use of qualitative research or reporting of 
modifications during procedure development.  Better education about research, integration of 
evaluation work into routine practice and training, regulation and linkage of evaluation work to 
assessment and awards systems could foster further improvements in surgical evidence. IDEAL has 
probably contributed only slightly to the improvements described to date, but its uptake is 
accelerating rapidly. The need for the integrated evaluation template it offers for surgery and other 
complex treatments is becoming more widely accepted.   
 
INTRODUCTION  
Just over 20 years ago, the Lancet published one of its most provocative Editorials since the era of 
Thomas Wakley.  Entitled “Surgical research or comic opera”, it lampooned clinical research in 
surgery, contrasting current practice with the principles of the  Evidence-Based Medicine 
movement(1).  Surgeons reacted with anger, claiming that they faced special problems which 
  
frequently invalidated an approach based solely on randomised controlled trials(2, 3).  Their protests 
were not widely accepted, but the controversy ignited eventually proved constructive.  Enquiry 
began into why randomised controlled trials (RCTs) seemed to be so difficult to conduct in surgery, 
and from these studies a picture emerged which partly justified the surgeons’ original objections(4, 
5). Expert consensus conferences involving surgeons, EBM experts and others developed a credible 
description of the process of evolution of innovative treatments, in surgery and other disciplines 
where complex skilled procedures require adaptation to each individual patient.  This construct was 
termed the IDEAL Framework, referencing the terms used for the sequential stages in the 
evolutionary process (Idea, Development, Exploration, Assessment and Long-term study)(6-8).  The 
Framework provided a theoretical basis for arguments against randomisation from the first patient 
in these complex interventions.  Each stage in the IDEAL Framework frames specific questions to be 
addressed, and this led logically  to the development of the IDEAL Recommendations, a set of 
guidelines for study design and reporting aimed at answering these questions for each stage (See 
Table 1 for a recently updated version of both Framework and Recommendations)(8, 9). 
The IDEAL Recommendations have been widely recognised as a rational approach to developing an 
integrated evaluation pathway for surgery and other complex interventions.  Since they describe  
desirable properties for clinical studies of surgery, they have obvious potential as a yardstick for 
judging the methodological progress of surgical research.  In this article we look first at how surgical 
research has developed in the last 20 years, using adherence to the IDEAL Recommendations as a 
measure of progress.  We then consider what impact IDEAL has had to date, how surgical research 
could be further improved, and what role IDEAL could play in that process in the future.   
WHAT IS SURGICAL RESEARCH? 
During the last 60 years we have seen the development of cardiac and vascular surgery, organ 
transplantation, joint replacement, minimally invasive surgery and most recently robotic surgery, 
advances of unquestionable importance to patients which have been based on surgical research.    
However many leading university departments of surgery emphasise research on topics such as the 
molecular genetics of diseases treated by surgery, the immunology of organ transplantation and 
rejection, or stem cell treatments.  Perhaps because of this, the direct study of outcomes from 
technical innovation such as minimally invasive and robotic surgery and new surgically implanted 
devices has been taken forward just as much by “non-academic” surgeons as by professional 
researchers.   
In this article we have considered only studies of the outcomes of surgical techniques, i.e. papers in 
which the question addressed is around the effects of an operation, since the focus of 
methodological criticism of surgical research has always been on this evaluation of surgical efficacy 
and effectiveness. 
HOW HAS IT CHANGED?  
Published surgical research has been steadily increasing in volume year on year.  Using search terms 
based on the above narrow definition of surgical research (see Appendix 1) we identified 41 surgical 
RCTs in PubMed for the year 2000, and 246 for 2014. During the same time, the number of RCTs 
recorded yearly on PubMed as a whole increased from 11,515 in 2000 to 27,426. Non-randomised 
surgical outcome studies also showed a several-fold increase during this time.  Randomised trials 
may be increasing somewhat as a proportion of surgical outcomes studies, but this trend is not yet 
so clear that we can be sure.  In 2000, RCTs represented 30%  (41 of 138) of all outcome studies 
identified by our search criteria, and this rose to just under 50% (208 of 422) by 2011, but the figures 
  
of 48% (218 of 458) in 2012 and 38% (217 of 564) in 2014 did not support the impression of a rising 
trend  (Figure 1).  
 
 METHODOLOGICAL TRENDS IN QUALITY: AN IDEAL ANALYSIS  
An analysis of surgical research based solely on the proportion of studies which are RCTs gives an 
inadequate view of the changes in surgical research over time, because it does not acknowledge the 
importance of pre-RCT studies of innovations still undergoing modification. The IDEAL 
Recommendations specify a number of uncontroversial desirable features for clinical studies of 
surgical interventions, especially for these earlier stages of surgical research. Examining whether 
these specific features have become more prevalent in published work over the years allows us to 
look at the progress of surgical research methodology in greater depth and detail. The IDEAL 
Framework provides clear justification for the fact that only a minority of published surgical research 
is made up of RCTs.  However, for surgical research to make progress the validity and accuracy of the 
studies during the earlier stages of the evolution of new techniques prior to an RCT needs to 
improve in quality, as well as the RCTs themselves.  The 1990s critiques of the surgical literature 
were based largely on analysis of contemporary studies of techniques in these earlier stages, for 
which the retrospective case series was, at that time, the standard (and grossly inadequate) format 
for publication.  The IDEAL Recommendations specify desirable characteristics for early stage studies 
which the case series plainly lacked.  We were interested in whether compliance with specific IDEAL 
Recommendations had improved since the first IDEAL publication, suggesting progress in the 
direction IDEAL recommended.  We therefore conducted a sampling exercise looking at studies from 
2000-2004 and from 2010-2014, the latter being the first full 5 year period after the publication of 
the original IDEAL articles (See Appendices 1 and 2 for details). This exercise was not powered to 
  
demonstrate statistical significance, so our comments on the trends we found are necessarily 
tentative.  The Recommendations we studied and the classes of study from which the samples were 
selected are shown in Table 2. 
The proportion of papers reporting prospective (as opposed to retrospective) studies remained 
about the same over the decade between the two eras; it was 60% (15/25) in 2000-2004 and 64% 
(16/25) in 2010-14.  The procedure was reasonably well described in nearly all cases in both cohorts. 
By contrast information about the quality of surgery was rarely provided, although with some 
apparent improvement over time.    
The IDEAL recommendations for early development studies in Stage 2a stress the need for an 
account of changes to the procedure or indications during the development process. This remains 
relatively rare (16% (4/25) in both eras).   
The IDEAL Recommendations suggest prospective collaborative collection of non-randomised data 
as a preparatory step towards multicentre RCTs.  We found that the proportion of randomised trials 
which referred to such data collection nearly doubled in the later sample (9/25 or 36%) compared to 
the earlier one (5/25 papers, 20%).  Although none of the sampled papers referenced the IDEAL 
Recommendations, it appears that stepwise progression from collaborating on prospective data 
collection to doing a trial together is becoming more common.   
Blinding or masking of outcome assessors in RCTs was reported in 6/25 (24%) of trials in the earlier 
period and in 10/25 (40%) in 2010-14.  There were no examples of the use of preparatory qualitative 
studies in any of the RCTs sampled in either epoch. The proportion of studies in which action was 
taken to address the issue of bias introduced by operator learning curves increased from 5 (20%) in 
the earlier epoch to 11 (44%) in 2010-2014. Only two (8%) of the randomised trials sampled 
between 2000 and 2004 explicitly mentioned the use of pilot/feasibility work prior to the RCT. None 
made reference to the CONSORT guidelines. By 2010-2014 reference to previous pilot work had not 
increased (one study), but five studies (20%) made reference to the CONSORT guidelines, and 12 
included a study flowchart. In both epochs absence of evidence of difference (p>0.05) in 
underpowered studies was routinely but incorrectly taken to be evidence of no difference between 
techniques.   
ANALYSIS AND FORWARD VIEW 
Surgical research seems to be changing for the better, although not as fast as we might wish.  Over 
ten years there have been clear improvements in the proportion of studies using CONSORT and 
using standardised terminology to report key data items, and an increase in the percentage of 
surgical RCTs that have been developed from prior prospective collaborative data collection efforts 
(as recommended by IDEAL for Stage 2b).  A higher proportion of surgical RCTs now describe 
blinding of outcome assessors, and there is better evaluation of the quality with which surgery is 
delivered (including evaluation of learning curves).  Surgeons are beginning to appreciate that 
properly designed preliminary studies are usually necessary before a successful surgical RCT, but the 
IDEAL proposition of an integrated evaluation pathway with identifiable stages has not yet become 
widely accepted and understood.  Evidence of the distance still untravelled includes the persistently 
high proportion of retrospective case series in the literature and the rarity of qualitative research to 
inform the development of RCTs.  Another indicator of the persistent weaknesses of surgical 
evaluation is the list of surgical procedures introduced during the periods under study whose 
widespread adoption without an adequate research base has harmed patients or driven up costs – 
including robotic prostatectomy(10) and the metal-on-metal hip resurfacing techniques(11).   
  
We know little about what influences methodological decision-making amongst surgical researchers, 
but some factors appear fairly obvious.  There are still strong career incentives for publishing poor 
research in surgery, particularly retrospective case series, and it is easy to find clinical journals that 
will accept them uncritically.  They are generally exempt from many of the regulatory hurdles which 
challenge prospective research and therefore represent a cheap, rapid route to publication.  As long 
as this form of research retains its value for career advancement it is unlikely to disappear.  On the 
other hand, the very difficulties which stimulated the development of IDEAL still make surgical trials 
difficult to organise, and there is no correlate for the abundant commercial funding available for 
pharma trials.  The weakness of basic training in the principles of clinical research for surgeons is a 
third important obstacle to progress.   
 What impact has IDEAL had since its inception in 2009?  Citation growth suggests an accelerating 
upward trajectory (BMC surgery, MS under review) but just as occurred with the EBM movement, 
understanding lags behind familiarity, and practical use is still further behind.  Use in the Health 
Technology Assessment community has however, made a strong start, with programmes in 
Canada(12) and the Netherlands(13) that use IDEAL to guide evaluation of medical technologies and 
devices.  A recently launched enterprise to offer device manufacturers a comprehensive evaluation 
service for innovative new products, EXCITE International(14), has embraced IDEAL as a central part 
of its methodology. NIHR has specified IDEAL 2b-type studies in several recent calls, and discussions 
about practical use of IDEAL in the NHS Commissioning through Evaluation project have been held 
with NHS England and with NICE.   
What changes could encourage the development of high quality research in surgery?  Those who can 
influence the research environment are those responsible for educating and training surgeons and 
those who decide which research gets funding and publication(8).  The adoption of higher standards 
by surgical journals  would be a major step forwards. Journal editors could, relatively easily, 
challenge the publication of traditional case series and request IDEAL Development or Exploration 
studies instead, except in very rare situations.  This could help to reduce research waste by lowering 
the prevalence of small ad-hoc mini RCTs or single arm studies trying out a new technique with no 
future implementation pathway or plan..  Clear support from research funders for composite 
proposals incorporating IDEAL-type pre-RCT pilot/feasibility studies would quickly modify the 
behaviour of the clinical research community.   
The complaint, voiced 20 years ago, that surgeons were surprisingly ill-educated about the principles 
of scientific methodology for investigating treatments is equally valid today, even in countries where 
EBM has flourished.  Medical schools and surgical training programmes are still failing to produce 
graduates who understand the methodological basis of clinical research and are able to apply this 
knowledge.  Correcting this will require more than just courses of study, since this type of complex 
applied knowledge can only be thoroughly incorporated through experiential learning.  Current 
surgical training in most countries separates academic and clinical work in an artificial and unhelpful 
way, with segments for dedicated “research time” and separate career tracks for academic and non-
academic surgeons.  As we saw with the minimally invasive and robotic revolutions, this risks 
creating a situation where the drive to innovate and the ability to evaluate are separated, to the 
detriment of evidence-based progress.  Having a clinical workforce who are not afraid to set up 
simple early-stage data collection efforts which will yield valid and useful results would be a major 
contribution to improving both quality and quantity in surgical research.  One very welcome recent 
development has been the successful surgical trainee research collaborative movement in the UK*.  
These groups give trainees practical participative experience of research, and have demonstrated 
their ability to recruit patients at impressive rates and minimal cost.  Their ability to develop RCTs on 
  
important questions is limited by their memberships’ situation, but they have enormous potential to 
conduct IDEAL 2b studies rapidly and effectively, and to use these to drive the funding and 
development of a subsequent RCT.   
As well as opportunities to do clinical research as an integral part of training, achieving true 
integration of research and practice will require appropriate incentives for both trainees and 
established surgeons in “non-academic” posts.  The distinctions we currently make between 
research, audit and quality improvement are often unhelpful, and it may be more useful to talk of 
involvement in scientific evaluation.  Linking involvement in high-quality evaluation to appraisal, 
tenure and rewards structures may be helpful, but so may public recognition, and opportunities to 
develop other initiatives.  Making institutional approval for innovative practice conditional on 
agreement to collect and submit appropriate data to the host institution, or for publication, would 
be a powerful way of enhancing evidence accumulation. Regulation may also help.  The regulatory 
framework  can influence the success and integration into clinical practice of Registries, as the 
success of Sweden in this area shows(15).  However regulation is usually most effective where 
popular opinion has already been won round to the ideas behind it, as the examples of restrictions 
on drink driving and smoking in public places illustrate  
VISION FOR THE FUTURE 
Surgical research is getting better, although it still has a long way to go.  It was unfairly maligned in 
the first place, as understanding of the real problems it faced was under-developed 20 years ago.  
The IDEAL Framework and Recommendations have probably contributed only in a minor way to the 
improvements seen so far, but their influence is growing, they are very useful as a yardstick to 
measure progress, and they represent a serious attempt to create a new paradigm for surgical 
research methodology.  The idea of a logical series of study questions and types based on the 
realities of how surgical operations evolve is clearly of value, and where IDEAL proves imperfect it is 
likely to be either modified or replaced by a better version, rather than by a return to 
methodological anarchy.  Because complex interventions typically require a period of iterative 
improvement before reaching a stable form, they cannot be subjected to valid comparisons with 
alternatives until this phase is over. The variety of influences on outcome which can be generated by 
subject heterogeneity and by variations in the quality of intervention delivery, especially whilst 
operators are learning, is practically infinite.  Defining a subject group and a version of the 
intervention for a trial will therefore require both a basis for decision making and considerable 
negotiation. Substantial prospective empirical data clearly represent a more reliable basis than 
theory combined with small datasets full of contextual biases.  Hence collaborative collection of non-
randomised data to assist with decision making it justified wherever complexity impedes definition 
of the study population or the intervention. 
These principles apply beyond the confines of surgery, and beyond conventional academic research. 
The concept of integrated stepwise evaluation, beginning with a study of development of the 
innovation and proceeding through more comprehensive evaluation of its properties and uses 
before comparing it with alternatives, seems applicable to complex interventions in many fields, 
both in healthcare and other domains. A version of IDEAL for evaluating therapeutic devices was 
published last year(16), and plans for using IDEAL in radiotherapy(17), physiotherapy(18), and 
acupuncture[Prof Xin Sun, personal communication] are being implemented.  Psychological 
therapies and complex social or quality improvement interventions are other areas where it may 
prove useful. 
  
The current version of the IDEAL Framework and Recommendations is clearly a work in progress.  
How it may need to be modified depends to a large extent on how clinical research methodology 
itself evolves.  For example, IDEAL’s current form is predicated on the assumption that RCTs will 
remain the “gold standard” methodology for comparing treatments.  This seems likely, but there is a 
danger that their increasing expense and regulatory complexity, combined with reluctance to 
participate in cultures which value the individual’s right to choose as paramount, and competition 
from the application of sophisticated risk adjustment techniques to very large observational datasets 
may reduce their pre-eminence in the future.  However even a major change such as this would 
merely require the Framework to be adapted, rather than abolished: in other words, if IDEAL did not 
already exist, it would be necessary to invent it.  Now that a viable alternative is beginning to 
emerge, the culture of surgical case series and other weak study designs should be consigned to 
history, and an integrated evaluation pathway for surgery using methodology appropriate to the 
task should be adopted. 
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